Variable | PsA subjects (number = 270) |
---|---|
Male gender | 124 (45.9%) |
Age (years) | 51.73 ± 11.49 |
Disease subset | |
Axial + peripheral | 95 (35.2%) |
Peripheral | 95 (35.2%) |
Axial | 64 (23.7%) |
Mutilans | 16 (5.9%) |
MetS | 91 (33.7%) |
HS | 76 (28.1%) |
CPs | 58 (21.5%) |
Concomitant MTX | 111 (41.1%) |
Disease duration (years) | 4.87 ± 2.94 |
ESR (mm/h) | 18.05 ± 13.19 |
CRP (mg/L) | 2.64 ± 2.93 |
SJC | 3.77 ± 4.08 |
TJC | 11.93 ± 5.48 |
PASI | 1.48 ± 0.71 |
HAQ | 2.47 ± 1.45 |
VAS | 76.7 ± 20.12 |
Patient global VAS | 74.25 ± 22.38 |
Tender entheseal count | 10.97 ± 5.40 |
Hypercholesterolemia | 139 (51.5%) |
Hypertriglyceridemia | 92 (34.1%) |
Impaired fasting glucose | 20 (7.4%) |
Hypertension | 57 (21.1%) |
Smoking habit | 65 (24.1%) |
Obesity | 111 (41.1%) |